Patterns of Eye Diseases Among Patients Attending The Eye Investigation Unit of Sohag University Hospital

February 8, 2025 updated by: Mahmoud Abd Elwareth Mohamed, Sohag University

The goal of the work: is to assess the patterns of eye diseases in patients attending the eye investigation unit of Sohag University Hospital.organize the community education. The main question it aims to answer is

  • DOES eye disease blindness prevalence rate increase in women more than men?
  • What is the rate of glaucoma and other ocular diseases that causes irreversible blindness among the attending patients? Patients attending to the eye investigation unit of Sohag University Hospital in the period from January 2025 to December 2025 are being observed in this work to determine the eye diseases prevalence.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

This type of study is helpful to get an idea about the epidemiology of ocular disorders. It is necessary to organize the community education and ensure early treatment to reduce the prevalence of such diseases in the general population.

  • Aim of the work: is to assess the patterns of eye diseases in patients attending the eye investigation unit of Sohag University Hospital.
  • Study design: observational Cross-Sectional study.3
  • Patients and methods: all patients attending to the eye investigation unit of Sohag University Hospital in the period from January 2025 to December 2025.
  • Inclusion criteria: All patients referred to the eye investigation unit from the outpatient clinic of Sohag university hospital, private clinics or health insurance.
  • Exclusion criteria:

    1. Patients unable to measure visual acuity.
    2. Patients unable to measure intraocular pressure.
    3. Mentally retarded patients.
    4. Undiagnosed patients.
  • Time schedule:

    1. Twelve months for collection of data, writing the review of literature and methodology.
    2. Three months for analysis of data and writing the results.
    3. Three months for writing the discussion and conclusions.
  • ethical considerations:

    1. The study adheres to Tents of Helsinki declaration.
    2. The study will be approved by the ethical committee of the faculty of medicine Sohag University.
    3. An informed written consent will be taken from all of the participants in the study or their guardians

Study Type

Observational

Enrollment (Estimated)

7000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: mortada AH Prof\ abuzaid, Professor
  • Phone Number: 093 01203324446

Study Locations

      • Sohag, Egypt, 82524
        • Recruiting
        • Faculty of Medicine in Sohag University
        • Contact:
        • Contact:
          • Mortada AH Prof\ Abozaid, professor
          • Phone Number: 093 01203324446

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

all patients attending to the eye investigation unit of Sohag University Hospital in the period from January 2025 to December 2025.

Description

Inclusion Criteria:

- All patients referred to the eye investigation unit from the outpatient clinic of Sohag university hospital, private clinics or health insurance.

Exclusion Criteria:

  • Patients unable to measure visual acuity.
  • Patients unable to measure intraocular pressure.
  • Mentally retarded patients.
  • Undiagnosed patients.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
determine the pattrens of eye diseases among patients attending the eye investigtion unit of sohag university
Time Frame: 1. Twelve months for collection of data, writing the review of literature and methodology. 2. Three months for analysis of data and writing the results. 3. Three months for writing the discussion and conclusions.
recording data of the prevalence of each eye disease among the study group in the period from January 2025 to December 2025 .their percentage in men and women , also in which age group
1. Twelve months for collection of data, writing the review of literature and methodology. 2. Three months for analysis of data and writing the results. 3. Three months for writing the discussion and conclusions.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: mortada AH Prof\ abuzaid, Professor, depatement of ophthalmology ,sohag university

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2025

Primary Completion (Estimated)

December 31, 2025

Study Completion (Estimated)

June 30, 2026

Study Registration Dates

First Submitted

February 1, 2025

First Submitted That Met QC Criteria

February 1, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 8, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Soh-Med--25-1-10MS

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Eye Diseases

Clinical Trials on eye investigations

Subscribe